HTI-286, a synthetic analogue of the tripeptide hemiasterlin, is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivo.

Source:http://linkedlifedata.com/resource/pubmed/id/12702571

Cancer Res. 2003 Apr 15 63 8 1838-45

Download in:

View as

General Info

PMID
12702571